Category: Events
Haves and Have Nots in Biotech Venture Capital
Recent data from the BIO Industry Analysis team tells a story of “haves and have-nots” …
BIO Investor Forum Closes with Record Attendance
The 14th Annual BIO Investor Forum wrapped up in San Francisco yesterday, having exceeded all …
Fireside Chat: “Everything we knew in science 10 years ago is wrong.”
The speed of scientific innovation these days is comparable to the PC innovation era of …
Stretching Your Dollar: Methods and Tools for Increasing the Productivity of Clinical Trials
Recent Tufts data show clinical trials typically take nearly twice as long to complete enrollment …
Fireside Chat: James Noble Says Go for IPO
“Go for it,” was the parting advice James Noble, CEO and co-founder of Adaptimmune, had …
Biotech Policy Outlook at #BIF15: 21st Century Cures, IPR, TPP, and PDUFA VI
To even the most casual observer, 2015 has been a big year in the biotech …
BIO Investor Forum Session Recap: Precision Medicine: Leveraging National Genomic Databases for Ther...
As the price point for full genome analysis falls through the $1,000 per person milestone, …
BIO Investor Forum Newly Added Sessions - Digital Health Spotlights
We are pleased to announce that two “digital health spotlight” sessions have been added to …
See What’s New at the 2015 BIO Investor Forum
The 2015 BIO Investor Forum is just two weeks away, and it’s gearing up to …
Emerging Themes in Personalized Medicine
The adoption of Personalized Medicine is being driven by the omnipresence of Next-Generation Sequencing (NGS), …